Researchers seek permission for starting clinical trial of Globe Biotech's Covid-19 vaccine

Researchers of Clinical Research Organisation (CRO) have sought permission for starting clinical trial of Bangavax, developed by Globe Biotech Ltd.

They submitted an application to Bangladesh Medical Research Council (BMRC) seeking the permission.

The researchers have proposed first and second phase clinical trial in their proposals.

Dr Mamun Al Mahtab, Professor of Hepatology department at BSMMU; Prof Tahmina Shirin, director of IEDCR; and other officials of the research organisation and Globe Biotech Ltd were present during the submission of the proposal.

On January 6, the Directorate General of Drug Administration issued permission to produce necessary vaccine doses for clinical trial.